No description available.

In Indiana, Ixodes scapularis is an important tick in public health because it feeds on a variety of hosts including humans, and transmits Borrelia burgdorferi (Lyme disease), Anaplasma phagocytophilum (human granulocytic ehrlichiosis), and Babesia microti (babesiosis). Symbiotic, non-pathogenic Rickettsia found in Ixodes scapularis may play a role in excluding pathogenic species of Rickettsia from being transovarially transmitted. In order to investigate this idea further in Indiana, a total of 378 adult I. scapularis from 4 different counties (Jasper, Pulaski, Newton and Starke) were tested by polymerase chain reaction analysis (PCR) for the presence of Rickettsia sp. Four positive samples from the PCR (using Rocky Mountain spotted fever group specific primers to target the rOmpA gene; Rr190.70p and RH 90.602n) reactions were sequenced to verify identity. These four samples matched closest to the reference number AB002268 from GenBank which describes, I. scapularis endosymbiont DNA for rOmpA. A total of 62 engorged females were tested; 53 (85.5%) harbored the rickettsial symbiont. A total of 41 questing females were tested; 33 (80.5%) were positive. Of the 249 males tested, 14 (5.6%) were positive. A restriction digestion on some of the positive samples revealed that the 1 scapularis symbiont was different from R. montana and R. rickettsii. The second goal of this study was to identify the presence of B. microti. In I. scapularis ticks, this would be the first time this pathogen was identified in Indiana. To accomplish this goal 106, ticks were tested using the primers Babl and Bab4, which target the 18S rRNA gene specific for B. microti. Three tick samples were found to harbor B. microti as determined by sequencing. However, sequencing of amplification band in the negative control also yielded B. microti. Thus, the presence of B. microti in Indiana ticks could not be confirmed. A negative control was also sequenced and was identified as Babesia microti indicating that there was a contamination so it is not possible to conclude that B. microti was found in Indiana ticks. / Department of Physiology and Health Science

Growing incidence of infections caused by the tick-transmitted protozoan parasite Babesia spp. defines babesiosis as an emerging disease from the aspect of human and veterinary medicine. The thesis provides an insight to biology of two main agents of human babesiosis, Babesia microti and Babesia divergens. We introduce here the fully optimized quantification model of Babesia parasite enabling the detailed investigation of the parasite developmental cycle and identification of molecules playing a role in its acquisition and transmission by the vector Ixodes ricinus. Novel and detailed information about Babesia dissemination within the tick tissues are given by newly implemented visualization and quantification techniques. Special emphasis is paid to parasite development in the tick salivary glands, the primary site responsible for parasite transmission from the vector into the host. Using gene-specific silencing we screene the tick immune pathways including effector molecules and evaluate their role in Babesia acquisition. We also provide a detailed view to Babesia parasite sexual commitment by monitoring its kinetics upon various stimuli. Moreover, a new direction of anti-babesial therapy is proposed by validation of the Babesia proteasome as a drug target. Overall, the research presented in the thesis extends the current knowledge of the Babesia parasite biology including molecular interactions at the tick-Babesia interface and thereby could significantly contribute to a potential control of babesiosis.

<p dir="ltr">Human babesiosis is a malaria-like, tick-borne infectious disease of major public health importance with a global distribution. Babesiosis is caused by intraerythrocytic, apicomplexan parasites of the genus Babesia. In the United States, human babesiosis is primarily caused by Babesia microti and Babesia duncani. Of these parasites, B. duncani infection is lethal to susceptible patients. Current treatment for babesiosis includes either the synergistic use of atovaquone and azithromycin or the combination of clindamycin and quinine. However, the side effects and the resistance posed by these parasites called for alternative approaches for the treatment of human babesiosis. Parasite-derived proteases play several functions in the context of parasitic lifestyle and regulate basic biological processes including cell death, cell progression and cell migration. We hypothesized that proteases are promising class of drug targets in Babesia parasites. Using the SYBR-Green assay, we screened a protease inhibitor library consists of 160 compounds against B. duncani in vitro culture at 50µM and identified 13 preliminary hits. Additionally, dose response assays of hit compounds against <i>B. duncani</i> and <i>B. microti</i> in vitro cultures identified 5 compounds as effective inhibitors against parasite growth. Of these 5 compounds, we chose ixazomib, a proteasome inhibitor as a potential drug for further studies based on its lower IC50 of 58nM as well as a higher therapeutic index as compared to other hit compounds. We demonstrated that in a mouse model infected with <i>target,</i>, the most effective inhibitor, the prodrug of ixazomib at a low dose of 2.5mg/kg lowers parasite proliferation without causing any adverse effects in animals. Thus, our studies suggest that Babesia proteasome may be an important drug target, and ixazomib may be a potential compound that may be used for the treatment of human babesiosis.</p>

Babesia microti is a tickborne hemoprotozoan parasite that causes the disease babesiosis in humans. Babesia microti Apical Membrane Antigen-1 (AMA-1) is a micronemal protein suspected to play a role in erythrocyte invasion. To investigate interaction between AMA-1 and the host cell, the ectodomain region of the B. microti ama-1 gene was cloned into an expression vector, expressed as a histidine-tagged fusion protein, and used to probe red blood cell membrane proteins in far Western blot assays. The B. microti ama-1 ectodomain, which excludes the signal peptide and the transmembrane region of the open reading frame, was amplified from a cloned gene sequence. The AMA-1 ectodomain is a membrane bound polypeptide that extends into the extracellular space and is most likely to interact or initiate interaction with the host red blood cell surface receptor(s). The amplicon was ligated into a protein expression vector to produce a 58.1 kDa recombinant His-tagged fusion protein, which was confirmed by Western blot analysis. The recombinant B. microti AMA-1 fusion protein was enriched on nickel affinity columns and then used to probe mouse, human and horse red blood cell membrane proteins in far Western blot assays. Babesia microti AMA-1 consistently reacted strongly with a protein migrating at 49 kDa. A similar reaction occurred between the B. microti AMA-1 and horse red blood cell membrane proteins, suggesting that similar interacting proteins of this size are shared by red blood cells from the three species. The B. microti AMA-1 may bind to red blood cell membrane sialic-acid groups, as shown for other Babesia spp. This may explain the signal at the 49 kDa position observed between B. microti AMA-1 and red blood cell membrane proteins from three different species. Further studies may determine if the binding epitopes of the red blood cell binding partner at this position vary and contribute to the specificity of each parasite AMA-1 for their respective host cells.

Lyme disease is an emerging tick-borne illness in Canada, with human case numbers increasing 15- to 20-fold since Lyme disease became nationally notifiable in 2009 until the present. In Ontario, Canada's largest province by population, average Lyme disease incidence across the province is similar to that of national estimates. However, in eastern Ontario, which is near tick endemic regions in the northeastern Unites States, Lyme disease incidence is disproportionately higher compared to the rest of the province. The objectives of this thesis are to identify environmental Lyme disease risk areas in Ontario, to explore spatiotemporal trends in Lyme disease emergence, and to identify neighbourhood-level socioecological risk factors for Lyme disease. In addition, this thesis also aims to assess the risk of other tick-borne illnesses that are transmitted by the blacklegged tick, Ixodes scapularis, which is also the main vector for Lyme disease in Canada. Using maximum entropy species distribution modelling to correlate blacklegged tick occurrence data with environmental variables, predictive risk models for I. scapularis and the Lyme disease pathogen, Borrelia burgdorferi, were developed. The model prediction was used to classify low and high environment risk areas and, using a case-control epidemiological study, we assessed that residence in risk areas was a strong predictor of Lyme disease. However, this relationship was modulated by socioecological factors linked to higher overall rurality of the locality of home residence. Spatial cluster analyses further revealed that human Lyme disease cases clustered in regions with the high numbers of reported B. burgdorferi-infected ticks in the environment. Many individuals residing in large metropolitan regions, like the City of Ottawa, reported tick exposures outside their public health unit of residence; however, local clusters of Lyme disease were also detected in suburban regions near conservation areas, trails, and urban woodlands. The prevalence of other tick-borne pathogens was low, although several pathogens of public health significance including Borrelia miyamotoi and Anaplasma phagocytophilum were detected at multiple sites surveyed for ticks between 2017-2021. Overall, this thesis identify patterns in Lyme disease emergence (and potentially other tick-borne illnesses), defines environmental risk areas for Lyme disease in Ontario, and highlights important socioecological risk factors for Lyme disease in eastern Ontario.

No description available.